The enzymes and external secretion of the pancreas are produced by the acinar cells.' For an adequate understanding of pancreatitis, a great deal must be learned about the specific metabolism of these cells, inasmuch as at present there are relatively few established facts. The oxidative metabolism of the pancreas is apparently very similar to that of other tissues as indicated by (i) a Q02 for pancreas slices of 6-7;18 ' (ii) accumulation of citrate in the pancreas of the fluoroacetate-treated animal; and (iii) accumulation of isotope of labeled acetate and labeled pyruvate in the glutamate pool of the pancreas."' Evidence for very active protein synthesis has been obtained from studies in which isotopically labeled amino acids have been injected into animals in vivo. In the rat, labeling of protein with isotopically labeled lysine or glycine was greater in the pancreas than in any other tissue studied;" in the dog, only the duodenal mucosa was as active in labeling of protein.'0 The quantity of protein produced by the human pancreas has been calculated as 10-20 grams, i.e., one to two liters of exocrine secretion daily with a 1-2 per cent concentration of enzymes." '2021 In some animals 20 per cent of the dry weight of the gland consists of enzymes with trypsin, amylase, lipase, and ribonuclease comprising 10, 5, 23/2, and /2 per cent respectively of the dry weight." Attempts to study synthesis of pancreatic enzymes in vitro have only gone as far as demonstration of enzyme synthesis by pancreatic slices. Hokin initially injected animals with cholinergic compounds to deplete the pancreas of enzymes;`' he then incubated pancreas slices in media supplemented with amino acids, and found that the enzymatic concentration increased in the medium after the slice had been stimulated with carbamyl choline.
THE EXOCRINE SECRETION OF THE PANCREA As indicated in Table 1 , the exocrine secretion of the pancreas contains a variety of hydrolytic enzymes, including the peptidases, trypsin, chymotrypsin, and carboxypeptidase, the glycosidases, amylase and maltase, the esterases, cholesterol esterase and lipase, and the nucleases, ribonucleases and deoxyribonuclease.'
Peptidases. Trypsin and chymotrypsin are normally present in the pancreas as the inactive precursors, i.e., trypsinogen and chymotrypsinogen. Activation of both enzymes results from hydrolysis of a "protective" peptide from the main enzyme molecule. Trypsinogen is a protein which contains the peptide chain, valyl -aspartyl-aspartyl-aspartyl-aspartyl-lysyl-isoleucine; in its activation to trypsin by trypsin, hydrolysis of the lysyl-isoleucyl bond results in the liberation of the active trypsin and the free hexapeptide, valylaspartyl-aspartyl-aspartyl-aspartyl-lysine.' In the duodenum and jejunum, trypsinogen is converted to active trypsin by the enzyme enterokinase." "'1l
The mechanism of the activation is not established, but is not simply a release from the inhibition of pancreatic trypsin inhibitor." Since trypsin itself can activate trypsinogen as noted above, the process is autocatalytic once started; calcium ion is an activator for the reaction."'" Trypsin is an endopeptidase attacking proteins either at the center or ends of the molecule at peptide bonds of the basic amino acids, arginine, and lysine on the amide linkage joining the carboxyl of these amino acids to the adjacent amino acid (Table 1 ).9 The proteolytic activity of trypsin has been applied therapeutically for enzymatic debridement of ulcerating or other chronic infections. ' Chymotrypsinogen is a precursor of the proteinases grouped as chymotrypsin (Table 1 ). In the course of its activation by trypsin, the "protective" peptide side chain is split off gradually resulting in a series of active chymotrypsins, including alpha, beta, and gamma chymotrypsins," pi chymotrypsin,U and delta chymotrypsin."8 Alpha chymotrypsinogen is a crystalline compound containing a peptide chain, leucyl-seryl-arginyl-isoleucyl-valine. In the pi chymotrypsin, the terminal isoleucyl-valine dipeptide has been split off the parent protein, while the delta form is the result of the loss of the seryl-arginine dipeptide." The chymotrypsins differ from trypsin in their ability to clot milk; their substrate specificity is also different from that of trypsin, since they require either an aromatic ring, such as that found in tryosine,9 phenylalanine, and tryptophan or methionine"8 adjacent to the peptide bond which they attack.
Carboxypeptidase. In addition to the endopeptidases, trypsin and chymotrypsin, the pancreas also secretes carboxypeptidase, an exopeptidase which attacks only terminal peptide bonds. This enzyme attacks the terminal peptide bond of a chain of amino acids at the carboxyl end of a polypeptide. '4 Trypsin inhibitors. The first of the trypsin inhibitors was isolated and crystallized from pancreas by Kunitz and Northrop and was shown to combine with trypsin stoichiometrically to yield a third protein possessing no proteolytic activity.' Inhibitors of trypsin have been isolated from a variety of sources, including soybeans, lima beans, and intestinal parasites such as Ascaris.64 " 90 These compounds are polypeptides or proteins with molecular weights ranging from 8,000-40,000 and they are thought to combine with trypsin in a 1: 1 ratio. The tenacity of their binding with trypsin is evident from the dissociation constant of the trypsin-inhibitor (pancreatic) complexes which have been estimated as 2 x 10"°M.-8-0 64, The inhibition was originally thought to be noncompetitive, but Green has shown that the ethyl ester of the substrate, benzoyl-L-arganineamide, protects the enzyme against the pancreatic inhibitor. Green also found that DFP (diisopropylfluorophosphate), which itself inhibits tryptic activity, protects the enzyme against combination with the pancreatic inhibitor and suggested that the inhibitor combines with the enzyme at the "active site."e" ' Chymotrypsin is also inhibited by DFP.
Tests of tryptic activity. Two clinical methods are useful for testing for intestinal activity of this enzyme group. In the first, hydrolysis of gelatin is measured either by a viscosimetric procedure which estimates liquefaction of gelatin5 or by the clearing of a spot on the x-ray film by a known dilution of a fecal suspension." In each instance, a negative test is of little significance, since trypsin itself is hydrolyzed in the passage of the intestinal contents through the gut. The methods are most applicable in pediatric practice, since the stools of infants are generally soft and moist; in the adult, desiccation and hardening of the stool is associated with destruction of the enzyme.' A second method for the determination of proteolytic activity is the study of the stool for meat fibers (creatorrhea).7' This test is of some use in testing for pancreatic insufficiency. (Table 1) .' This enzyme has a molecular weight of 45,000 and has the characteristics of an alpha amylase, i.e., it attacks the internal bonds of the polysaccharide and does not release single glucose units.' The enzyme specifically attacks the a-1, 4-glucosidic bond and exhibits no significant activity on structures with the 8-glycosidic linkage. Pancreatic amylase hydrolyzes starch to maltose and trisaccharides and is activated fourfold by the addition of chloride ion. As far as can be determined, pancreatic amylase is the same enzyme as salivary amylase. The products of the hydrolytic activity of pancreatic amylase are hydrolyzed to glucose by maltase.
Tests for amylase activity. The clinical methods applied to the determination of amylase activity at present are "saccharogenic" or "amyloclas- Lipase. Pancreatic lipase is an esterase which is apparently the only lipase secreted in significant quantity or activity in the gastrointestinal tract. In general, it is. more active toward triglycerides containing long chain, unsaturated fatty acids. The end-products of its activity are a mixture of diglycerides, monoglycerides, fatty acids, and glycerol. The optimum pH for the enzyme is 7-8 and the activity is enhanced by the addition of bile salts, calcium ion, and various peptides to the medium. Following the report of Elman on the usefulness of amylase studies for diagnosis of pancreatic inflammation, Cherry and Crandall reported an increase in plasma lipase activity in pancreatic obstruction. 22 The technique used for determination of the activity of the enzyme requires a 24-hour incubation of 5 cc. of a buffered suspension of olive oil with 1 cc. of serum at 40' followed by titration of the liberated fatty acids. Unfortunately, the long incubation period has precluded the use of this technique as a routine procedureq' and more soluble substrates are being sought in an effort to shorten the required incubation time.`nl In chronic pancreatic insufficiency, the lack of pancreatic lipase results in steatorrhea and the excretion of foul, greasy stools. The fat may be seen microscopically by staining the stool with Sudan IV or it may be determined gravimetrically ;7 an increase in the percentage of lipid from the normal value of 10-20 to 40-50 per cent of the total dry weight of the stool is very suggestive of pancreatic disease.' -'- ' In addition to the enzymes discussed above, the pancreatic secretion contains enzymes which have been less extensively studied, both from a clinical or biochemical point of view; these include cholesterol esterase, ribonuclease, and deoxyribonuclease. The endocrine secretion of the pancreas contains two other polypeptides, insulin and glucagon, but these play no apparent role in pancreatitis.
The inorganic compounds secreted by the pancreas are chiefly water and the ions normally found in the serum. Under the influence of secretin, the secretion of water increases markedly, and the bicarbonate ion concentration rises to the level of the chloride ion, i.e., from 6-30 mEq./liter to 120-130 mEq./liter, while the chloride ion concentration drops from 120 mEq./liter to 28 mEq./liter.`"`' In the secretin test for the study of pancreatic secretion, the average volume of secretion is 250 cc., generally containing 32 mEq. of base as alkali reserve. In the test meal for gastric acidity, an average of 180 cc. of 0.1 N base are required to neutralize the gastric secretion, i.e., 18 mEq. of acid are formed. The approximate equivalence of these values has been the source of speculation on the role of the pancreas in maintaining the normal duodenal pH and preventing peptic ulcer.59' It is thought that the circulating blood is the source of the bicarbonate of the pancreatic secretion, inasmuch as C1402 injected into secretin-treated animals appears promptly in the pancreatic secretion. Although the mechanism of transfer of the bicarbonate from the blood to the pancreatic secretion is unknown, it is suspected that carbonic anhydrase may play an important role, inasmuch as Diamox ® inhibits both the increase in bicarbonate as well as the increase in total volume.2 PHYSIOLOGICAL CONTROLS OF THE EXOCRINE SECRETION Secretin. Pavlov and his co-workers found that the flow of pancreatic secretion was initiated by the entry of gastric contents into the duodenum."' They also found that the pancreatic secretion varied with the diet, so that animals fed bread exhibited increased amylolytic activity, while a meat diet evoked the maximum tryptic activity. While this challenging observation has not been explained, it has been verified by other workers since that time.' Bayliss and Starling found that the increase in secretion evoked by acid was mediated by secretin,9 a polypeptide hormone formed by the duodenal mucosa and released into the blood stream in the presence of acid. Secretin has been crystallized and has been found to have a molecular weight of 5,000.7' Its amino acid composition has been studied by Agren and Willander who found that it contained much lysine 'and arginine, but no cystine, tyrosine, or tryptophan. 8 Secretin test for pancreatic function. The chief effects of secretin are the increases in volume and bicarbonate content of the pancreatic secretion and these effects are the parameters used in the secretin test for pancreatic function introduced clinically by Agren and Lagerlof."2' Following the intravenous injection of 0.75 mg/kg or 1 U/kg of the hormone, collection of the pancreatic secretion is carried out via a biluminal tube for an 80-minute period, in 1, 2, or 4 equal parts ;"`o2 @ the outer lumen of the tube separates gastric secretion from the duodenal contents which are collected from the center lumen. The response should include the secretion of a volume of 125-250 ml., with a bicarbonate concentration of 90-130 mEq./l., 90-1,200 U. of amylase, 20-120 U. of trypsin, and 7,000-14,000 U. of lipase.''"9'
Vagal stimulation. The physiological controls of the secretion of pancreatic enzymes have been less extensively studied. Mellanby and others noted that stimulation of the vagus nerves or administration of cholinergic compounds results in the secretion of a small quantity of fluid rich in enzymes;'-9' this secretion was found to be accompanied by discharge of zymogen granules of the pancreatic acinar cells. Similar effects have been obtained by the hormone pancreozymin which has been isolated from the small intestine by Harper Mechanism of release of trypsin. The basic question in the etiology of pancreatitis is what is the mechanism of activation and/or release of the trypsin? Kunitz has shown that crystalline trypsinogen continuously undergoes spontaneous breakdown to yield trypsin and this process is catalyzed by ammonium sulfate or magnesium sulfate.8' If this process were not rapidly and effectively suppressed in the pancreatic cells, acute pancreatitis would be a far more common clinical event than it is at present. A relatively small number of trypsin molecules would "autocatalyze" activation of a progressively increasing number of molecules to trypsin and chymotrypsin.8' It can be presumed that the large quantity of very effective pancreatic trypsin inhibitor suppresses this process in its inception. Evidence for this concept has come from studies of Kalser and Grossman who produced pancreatitis by daily administration of ethionine, an analogue inhibitor of methionine metabolism.8' They found an increase in the concentration of active trypsin in the pancreatic secretion and in the pancreas. Significantly, they found a depression in the ratio of the concentration of trypsin inhibitor to trypsin, both in the pancreatic secretion and in the pancreatic tissue.
These studies do not provide insight into the mechanism of reduction of trypsin inhibitor in human pancreatitis. However, a number of other theories for pancreatitis relate indirectly to this question. The older theories of pathogenesis of pancreatitis include: (i) the "obstruction-hypertension theory" which suggests that the pressure is elevated in the pancreatic ducts and function is suppressed by the ensuing increased cellular pressure;21l15l141O (ii) the "common channel theory" which suggests that there may exist a common channel between the bile ducts and the pancreatic ducts with bile acting as a hypothetical activating agent for trypsin ;`9 and (iii) the "oversecretion" theory which is supposed to account for the relationship of pancreatitis to alcoholism.84 "'' ' 0 Each of these possibilities may account for a temporary cessation of formation of trypsin inhibitor. If this inhibitor is normally the rate-limiting factor for activation of trypsinogen, its absence would result in a sudden increase in active trypsin in the gland, and thereby set off the whole hydrolytic process.
The chronic inflammation of the pancreas, chronic relapsing pancreatitis, is divided into two stages of recurrent pancreatitis and pancreatic insufficiency. Recurrent pancreatitis is considered to be a more localized acute interstitial pancreatitis, while the end-stage of pancreatic insufficiency results from fibrosis of the pancreas (Table 2) . Acute pancreatitis. The destruction of pancreatic tissue by proteolytic enzymes not only produces hemorrhage and necrosis,1'" but also liberates an active pool of other enzymes, including pancreatic lipase. The release of lipase is accompanied by hydrolysis of fat of the pancreatic tissue, the omentum and the mesentery. The freed fatty acids rapidly form insoluble calcium soaps by combination with calcium ion of the circulating blood.u' The formation of calcium soaps depletes the calcium ion in the plasma as was shown by Edmondson and Fields who found 100-1730 mg. of calcium in the pancreas of patients with pancreatitis.' Inasmuch as there is approximately 10 mg. calcium per 100 cc. plasma, the total in the blood of a 70 kg. man would be 350 mg. in 3.5 liters of plasma. The extracellular fluid contains approximately 5 mg./100 cc. or 575 mg. in 11.5 liters. Accordingly, the combined total for plasma and extracellular fluid is 925 mg. The large reservoir of calcium in the bones could easily replace the losses from the plasma and extracellular fluid in time, but the rate of replacement generally does not equal the rate of depletion. Edmondson and Berne found that the plasma level of calcium dropped to less than 9 mg./100 cc. in 72 per cent of cases studied and in a number of cases, levels of less than 7 mg./100 cc. were noted; tetany has been reported.""7
Serum levels of enzymes. The studies of Elman and coworkers, first reported in 1929, established the importance of the determination of the concentration of amylase in the blood for the diagnosis of acute pancreatitis."' It has been pointed out that normally all exocrine enzymes of the pancreas are found in small amounts in the blood;' however, pancreatitis alters the so-called "exocrine-endocrine partition" in the direction of an increased blood amylase, lipase, and possibly trypsin concentration. Elman et al. measured the rate of decrease in the viscosity of a starch solution as an indication of the concentration of amylase; they found an increase of 2-to 20-fold in activity of amylase in the serum of patients with acute pancreatitis. In terms of modern analytical values, the serum amylase increases from an average value of 150 Somogyi Units/100 ml. plasma to more than 500 U/100 ml. of plasma, and maximum values of 8,000 U/100 cc. plasma have been reported.'" In acute pancreatitis, these values remain elevated for 48-72 hours and then decrease to a normal level." The pancreatic amylase is excreted by the kidney and within two hours after the serum level has risen, the level in the urine increases; a confirmatory test for pancreatitis has been developed utilizing the urine amylase level.""' v" A marked rise in lipase of the blood is also noted and the level of this enzyme remains elevated for a considerably longer time than does the amylase level.''' 6@5 This test for pancreatic inflammation has been reported as 95-97 per cent positive. Thus far, a significant increase in trypsin level in the blood has not been found. It may be that the trypsin inhibitor in the blood complicates accurate estimation of this enzyme in the blood.`q' Chronic pancreatitis. In chronic pancreatitis, the progressive destruction of acinar tissue results in a decreased secretion of pancreatic enzymes. A similar pancreatic insufficiency is found in cystic fibrosis of the pancreas.' Steatorrhea, azotorrhea, and creatorrhea result in the formation of a bulky, greasy, foul stool, weight loss, and polyphagia."'0' Amylorrhea is not found, indicating the presence of adequate digestive enzymes for polysaccharides in the intestinal secretions. The presence or absence of creatorrhea, simply determined by observation of undigested meat fibers in the stool, may also be of significance in differential diagnosis of biliary deficiency and sprue, since creatorrhea does not accompany these diseases. The percentage as "split fat," or fatty acids, is low in pancreatic disease and this may be a useful point in differentiating sprue or biliary deficiency.""''' A result of steatorrhea is deficient absorption of fat soluble vitamins. After administration of Vitamin A to control subjects, the level in the plasma increased to 300 micrograms/100 ml. plasma from a control level of 50-100 micrograms/ 100 ml.' In contrast, a failure of increase in the plasma level of Vitamin A was noted in patients with cystic fibrosis of the pancreas or celiac disease. Administration of pancreatin resulted in a marked increase in the level of Vitamin A in the plasma of patients with cystic fibrosis of the pancreas. For therapy of secondary infections, antibiotics have been used either singly or in combination. Supportive therapy with cortisone and ACTH has also been studied.'0 ' In the recovery period, antacids are administered and stimulants of gastric secretion, such as coffee and alcohol, are omitted from the diet.
Chronic pancreatitis. In the various forms of pancreatic insufficiency, maintenance of nutrition is an important part of medical therapy. Replacement therapy with pancreatic enzymes has been used to combat the severe weight loss which accompanies pancreatic insufficiency. Raw pancreas or enteric coated pancreatin (N.F.) is administered orally in doses of 10-20 grams daily." While excellent amylolytic, lipolytic, and proteolytic activity has been reported for some preparations of pancreatic enzymes, carefully controlled studies on their fate and effectiveness are uncommon. The remainder of therapy is symptomatic and designed to prevent further attacks.
Surgery has a limited role in therapy of chronic pancreatic inflammation." "" "' Atropine-like drugs and analgesics may be utilized for relief of distress. Antacids may be administered and alcohol is prohibited. The mild diabetes which occasionally occurs is readily controllable with low doses of insulin.'
In summarizing therapy of pancreatitis, it is apparent that marked gaps exist between biochemical knowledge of normal pancreatic function, pathogenesis, and chemical pathology of the disease on the one hand, and the availability of specific therapeutic agents on the other. As biochemical pharmacodynamics advances, it seems reasonable to hope that useful drugs will become available which will inhibit the necrotizing effects of trypsin and other released pancreatic enzymes in acute pancreatitis. A more readily approachable problem would be the development of methods for preparation of very active purified enzymes for treatment of chronic pancreatitis.
